Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Mechanisms of vascular comorbidity in autoimmune diseases.

Nagy G, Németh N, Buzás EI.

Curr Opin Rheumatol. 2018 Mar;30(2):197-206. doi: 10.1097/BOR.0000000000000483.

2.

Folate depletion and increased glutamation in juvenile idiopathic arthritis patients treated with methotrexate.

Funk RS, van Haandel L, Leeder JS, Becker ML.

Arthritis Rheumatol. 2014 Dec;66(12):3476-85. doi: 10.1002/art.38865.

3.

Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion.

van den Oever IA, van Sijl AM, Nurmohamed MT.

Ther Adv Musculoskelet Dis. 2013 Aug;5(4):166-81. doi: 10.1177/1759720X13491025.

4.

A review of psoriasis, a known risk factor for cardiovascular disease and its impact on folate and homocysteine metabolism.

McDonald I, Connolly M, Tobin AM.

J Nutr Metab. 2012;2012:965385. doi: 10.1155/2012/965385. Epub 2012 May 29.

5.

Hyperhomocysteinaemia in Behçet's Disease.

Hamzaoui A, Harzallah O, Klii R, Mahjoub S.

Biochem Res Int. 2010;2010:361387. doi: 10.1155/2010/361387. Epub 2010 Sep 28.

6.

A personal journey from the joint to the heart.

Cronstein BN.

Arthritis Res Ther. 2010;12(4):134. doi: 10.1186/ar3099. Epub 2010 Aug 13.

7.

A1298C polymorphism in the MTHFR gene predisposes to cardiovascular risk in rheumatoid arthritis.

Palomino-Morales R, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Rodriguez L, Miranda-Filloy JA, Fernandez-Gutierrez B, Llorca J, Martin J, Gonzalez-Gay MA.

Arthritis Res Ther. 2010;12(2):R71. doi: 10.1186/ar2989. Epub 2010 Apr 26.

8.

Drugs to Treat Systemic Lupus Erythematosus: Relationship between Current Use and Cardiovascular Risk Factors.

Rho YH, Oeser A, Chung CP, Morrow JD, Stein CM.

Arch Drug Inf. 2008 Jul;1(1):23-28.

9.

Going with the flow: methotrexate, adenosine, and blood flow.

Cronstein BN.

Ann Rheum Dis. 2006 Apr;65(4):421-2. No abstract available.

10.

Pharmacogenetics in the rheumatic diseases.

Cronstein BN.

Ann Rheum Dis. 2004 Nov;63 Suppl 2:ii25-ii27. Review. No abstract available.

11.

Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene.

Berkun Y, Levartovsky D, Rubinow A, Orbach H, Aamar S, Grenader T, Abou Atta I, Mevorach D, Friedman G, Ben-Yehuda A.

Ann Rheum Dis. 2004 Oct;63(10):1227-31.

12.

Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity.

Vaudo G, Marchesi S, Gerli R, Allegrucci R, Giordano A, Siepi D, Pirro M, Shoenfeld Y, Schillaci G, Mannarino E.

Ann Rheum Dis. 2004 Jan;63(1):31-5.

13.

Arterial stiffness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis.

Klocke R, Cockcroft JR, Taylor GJ, Hall IR, Blake DR.

Ann Rheum Dis. 2003 May;62(5):414-8.

14.

Molecular action of methotrexate in inflammatory diseases.

Chan ES, Cronstein BN.

Arthritis Res. 2002;4(4):266-73. Epub 2002 Mar 19. Review.

15.
16.

Inflammation-mediated rheumatic diseases and atherosclerosis.

Manzi S, Wasko MC.

Ann Rheum Dis. 2000 May;59(5):321-5. No abstract available.

17.

Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis.

Haagsma CJ, Blom HJ, van Riel PL, van't Hof MA, Giesendorf BA, van Oppenraaij-Emmerzaal D, van de Putte LB.

Ann Rheum Dis. 1999 Feb;58(2):79-84.

Supplemental Content

Support Center